QC
INDV icon

Quadrature Capital’s Indivior Pharmaceuticals INDV Stock Holding History

Quadrature Capital’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$755K Buy
+24,768
New +$818K 0.01% 659
2025
Q4 		– Sell
-8,600
Closed -$207K – 1451
2025
Q3 		$207K Buy
+8,600
New +$180K ﹤0.01% 779
2024
Q2 		– Sell
-71,113
Closed -$1.52M – 1318
2024
Q1 		$1.52M Buy
+71,113
New +$1.34M 0.03% 364

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Quadrature Capital's INDV Position: Q1 2026 in Review

Quadrature Capital opened a new position in Indivior Pharmaceuticals (INDV) in Q1 2026: 24,768 shares worth $755K. The stake represents 0.01% of the portfolio and ranks #659 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in INDV as recently as Q3 2025.

Quadrature Capital first reported a position in INDV in Q1 2024 and has held it in 3 quarters since. The position peaked at $1.52M in Q1 2024. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Quadrature Capital held 24,768 shares of Indivior Pharmaceuticals worth $755K as of Q1 2026.
  • Indivior Pharmaceuticals was a new Quadrature Capital position in Q1 2026.
  • Indivior Pharmaceuticals made up 0.01% of Quadrature Capital's portfolio in Q1 2026, its #659 holding.
  • Quadrature Capital first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
  • Quadrature Capital's Indivior Pharmaceuticals position peaked at $1.52M in Q1 2024.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.